From: Comparisons of the survival time of patients with ovarian cancer adopting post-operative chemotherapy by use of paclitaxel combined with carboplatin or nedaplatin
Factors
Wald
P
Exp (B)
95 % CI
Lower
Upper
Age
2.694
0.101
1.03
0.994
1.068
Chemotherapy schemes
4.756
0.029
0.501
0.269
0.932
Pathological type
0.006
0.94
1.025
0.535
1.963